跳至主要内容
临床试验/NCT06362304
NCT06362304招募中不适用

Application of 99mTc-CNDG SPECT/CT Imaging in the Diagnosis of Brain Tumors

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
SUVmax

研究概览

简要总结

The goal of this clinical trial is to evaluate the value of 99mTc-CNDG for diagnosis of brain tumors by comparing it with 18F-FDG-PET. The main questions it aims to answer are:

  1. What is the diagnostic consistency between 99mTc-CNDG and 18F-FDG?
  2. What is the correlation between the SUVmax value of 99mTc-CNDG and tumor type?

Participants will:

Receive18F-FDG-PET and 99mTc-CNDG examination within 2 weeks before surgery. Obtain pathological diagnosis by surgery or biopsy as the gold standard.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with clinical diagnosis of brain tumor;
  • Be at least 18 years old;
  • The final pathological results could be obtained by surgery or biopsy;
  • Informed consent and the ability to be followed up;
  • Those who did not meet the exclusion criteria.

排除标准

  • Insulin-dependent diabetes mellitus or fasting blood glucose >7 mmol/L before 99mTc-CNDG injection;
  • Severe liver or kidney disease (serum creatinine level >3.0mg/dL or any liver enzyme level ≥ 5 times the upper limit of normal);
  • Severe hypersensitivity or hypersensitivity to radiocontrast agents;
  • Claustrophobia (inability to undergo SPECT/CT or PET/CT scans);
  • Patients receiving radiotherapy and chemotherapy;
  • Being pregnant or breastfeeding.

结局指标

主要结局

SUVmax

时间窗: 1month

1\. Diagnostic consistency evaluation of 99mTc-CNDG and 18F-FDG; 2.Correlation of SUV value of 99mTc-CNDGwith tumor type

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

99mTc-CNDG SPECT/CT in Brain Tumors | 临床试验